652153-48-5 Usage
Uses
Used in Pharmaceutical Research and Development:
TERT-BUTYL (6-CHLOROPYRAZIN-2-YL)CARBAMATE is used as a building block for the synthesis of various biologically active compounds due to its unique chemical structure and properties. Its potential applications in drug discovery are currently under investigation, with the aim of identifying its biological activity and possible therapeutic uses.
Used in Drug Synthesis:
In the pharmaceutical industry, TERT-BUTYL (6-CHLOROPYRAZIN-2-YL)CARBAMATE is used as a key intermediate in the synthesis of new drugs. Its chemical properties, including the presence of the pyrazine ring and the tert-butyl groups, make it a valuable component in the development of novel therapeutic agents.
Further studies are necessary to explore the full range of applications and potential uses of TERT-BUTYL (6-CHLOROPYRAZIN-2-YL)CARBAMATE in various fields, including medicinal chemistry, drug delivery, and other areas of pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 652153-48-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,2,1,5 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 652153-48:
(8*6)+(7*5)+(6*2)+(5*1)+(4*5)+(3*3)+(2*4)+(1*8)=145
145 % 10 = 5
So 652153-48-5 is a valid CAS Registry Number.
652153-48-5Relevant academic research and scientific papers
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors
Kuo, Gee-Hong,DeAngelis, Alan,Emanuel, Stuart,Wang, Aihua,Zhang, Yan,Connolly, Peter J.,Chen, Xin,Gruninger, Robert H.,Rugg, Catherine,Fuentes-Pesquera, Angel,Middleton, Steven A.,Jolliffe, Linda,Murray, William V.
, p. 4535 - 4546 (2007/10/03)
On the basis of previous studies, we identified pyrazine-pyridine A as a potent vascular endothelial growth factor inhibitor and pyrimidine-pyridine B as a moderately potent cyclin dependent kinase (CDK) inhibitor. A proposed combination of CGP-60474 and
SUBSTITUTED TRIAZINE KINASE INHIBITORS
-
Page 38; 39, (2010/11/30)
The present invention provides substituted 1,3,5-triazine compounds as kinase inhibitors and a method for treating or ameliorating a kinase mediated disorder.
